Lilly, Merck Deals Mark Start Of New Era For Indian Drug Firms – PharmAsia News Spotlight
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - A new patent law to protect intellectual property and in-depth experience in clinical trials and manufacturing has helped Indian drug firms such as Piramal Healthcare become equal partners with multinational counterparts in sharing risks, costs and profits, according to a senior company executive
You may also be interested in...
China Emerging As Big Winner In Pharma Outsourcing Rush To Asia -- PwC
Asia's expanding wealth and markets for drugs, combined with a pool of scientific talent and strengthening protections for patents, propel pharmaceutical multinationals to step up operations in the region.
China Emerging As Big Winner In Pharma Outsourcing Rush To Asia - PwC
BEIJING - Asia's expanding wealth and markets for drugs, combined with a pool of scientific talent and strengthening protections for patents, are propelling pharmaceutical multinationals to step up operations in the region in drug manufacturing, research and clinical trials
China Emerging As Big Winner In Pharma Outsourcing Rush To Asia -- PwC
Asia's expanding wealth and markets for drugs, combined with a pool of scientific talent and strengthening protections for patents, propel pharmaceutical multinationals to step up operations in the region.